David T Rubin1, Charles Sninsky2, Britta Siegmund3, Miquel Sans4, Ailsa Hart5, Brian Bressler6, Yoram Bouhnik7, Alessandro Armuzzi8, Anita Afzali9. 1. University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA. 2. Digestive Disease Associates, Gainesville, Florida, USA. 3. Charité - Universitätsmedizin Berlin, Berlin, Germany. 4. Gastroenterology Department/ISADMU, Centro Médico Teknon, Barcelona, Spain. 5. St. Mark's Hospital, London, UK. 6. University of British Columbia, Vancouver, British Columbia, Canada. 7. Inserm et Université Paris, Paris, France. 8. Fondazione Policlinico A. Gemelli IRCCS-Universita' Cattolica, Rome, Italy. 9. The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Abstract
BACKGROUND: Inflammatory bowel diseases (IBD), including Crohn disease (CD) and ulcerative colitis (UC), are complex disorders with multiple comorbidities. We conducted international patient and physician surveys to evaluate current experiences and perceptions of patients with CD or UC and physicians who treat IBD. METHODS: The IBD Global Assessment of Patient and Physician Unmet Need Surveys comprised a patient survey and a physician survey, fielded in North America and Europe between August 16, 2019, and November 10, 2019. Adults with CD or UC (targeted 1:1 ratio) were recruited from physicians, patient advocacy groups, and recruitment panels; physicians were recruited by recruitment agencies and panels. RESULTS: In total, 2398 patients with IBD (1368 CD, 1030 UC) and 654 physicians completed surveys. Anxiety and depression were the most common comorbidities among patients with IBD. Patients and physicians were generally aligned on treatment goals and patient-physician communication. Patients with IBD reported high quality-of-life impact by rectal urgency and need to use the toilet, which were rated as lower-impact by physicians. Patients defined remission based on symptoms; physicians defined remission based primarily on clinical tests. Patients expected current treatments to control their disease for a longer duration than did physicians. Patients expressed more concern about corticosteroid use compared with physicians; many physicians reported prescribing corticosteroids for more than 4 months per year in some patients. CONCLUSIONS: Patients could benefit from education about disease remission and expectations for current therapies. High corticosteroid use is concerning to patients, and physicians should minimize the use of corticosteroids for extended periods of time.
BACKGROUND: Inflammatory bowel diseases (IBD), including Crohn disease (CD) and ulcerative colitis (UC), are complex disorders with multiple comorbidities. We conducted international patient and physician surveys to evaluate current experiences and perceptions of patients with CD or UC and physicians who treat IBD. METHODS: The IBD Global Assessment of Patient and Physician Unmet Need Surveys comprised a patient survey and a physician survey, fielded in North America and Europe between August 16, 2019, and November 10, 2019. Adults with CD or UC (targeted 1:1 ratio) were recruited from physicians, patient advocacy groups, and recruitment panels; physicians were recruited by recruitment agencies and panels. RESULTS: In total, 2398 patients with IBD (1368 CD, 1030 UC) and 654 physicians completed surveys. Anxiety and depression were the most common comorbidities among patients with IBD. Patients and physicians were generally aligned on treatment goals and patient-physician communication. Patients with IBD reported high quality-of-life impact by rectal urgency and need to use the toilet, which were rated as lower-impact by physicians. Patients defined remission based on symptoms; physicians defined remission based primarily on clinical tests. Patients expected current treatments to control their disease for a longer duration than did physicians. Patients expressed more concern about corticosteroid use compared with physicians; many physicians reported prescribing corticosteroids for more than 4 months per year in some patients. CONCLUSIONS: Patients could benefit from education about disease remission and expectations for current therapies. High corticosteroid use is concerning to patients, and physicians should minimize the use of corticosteroids for extended periods of time.
Authors: Merih Oray; Khawla Abu Samra; Nazanin Ebrahimiadib; Halea Meese; C Stephen Foster Journal: Expert Opin Drug Saf Date: 2016-02-06 Impact factor: 4.250
Authors: Mark Löwenberg; Severine Vermeire; Nahid Mostafavi; Frank Hoentjen; Denis Franchimont; Peter Bossuyt; Pieter Hindryckx; Theo Rispens; Annick de Vries; C Janneke van der Woude; Sophie Berends; Carmen A Ambarus; Ron Mathot; Esme Clasquin; Filip Baert; Geert D'Haens Journal: Gastroenterology Date: 2019-06-05 Impact factor: 22.682
Authors: James M Dahlhamer; Emily P Zammitti; Brian W Ward; Anne G Wheaton; Janet B Croft Journal: MMWR Morb Mortal Wkly Rep Date: 2016-10-28 Impact factor: 17.586
Authors: Silvio Danese; Matthieu Allez; Ad A van Bodegraven; Iris Dotan; Javier P Gisbert; Ailsa Hart; Peter L Lakatos; Fernando Magro; Laurent Peyrin-Biroulet; Stefan Schreiber; Dino Tarabar; Stephan Vavricka; Jonas Halfvarson; Séverine Vermeire Journal: Dig Dis Date: 2019-02-06 Impact factor: 2.404
Authors: Paul Rutgeerts; Christopher Gasink; Daphne Chan; Yinghua Lang; Paul Pollack; Jean-Frederic Colombel; Douglas C Wolf; Douglas Jacobstein; Jewel Johanns; Philippe Szapary; Omoniyi J Adedokun; Brian G Feagan; William J Sandborn Journal: Gastroenterology Date: 2018-08-29 Impact factor: 22.682
Authors: Edward V Loftus; Jean-Frédéric Colombel; Brian G Feagan; Severine Vermeire; William J Sandborn; Bruce E Sands; Silvio Danese; Geert R D'Haens; Arthur Kaser; Remo Panaccione; David T Rubin; Ira Shafran; Megan McAuliffe; Arpeat Kaviya; Serap Sankoh; Reema Mody; Brihad Abhyankar; Michael Smyth Journal: J Crohns Colitis Date: 2017-04-01 Impact factor: 9.071
Authors: Chiara Rosso; Alami Aroussi Aaron; Angelo Armandi; Gian Paolo Caviglia; Marta Vernero; Giorgio Maria Saracco; Marco Astegiano; Elisabetta Bugianesi; Davide Giuseppe Ribaldone Journal: Nurs Rep Date: 2021-04-01